Vanqua Bio

Vanqua Bio is a Chicago-based biopharmaceutical company dedicated to discovering and developing next-generation drugs for the treatment of neurodegenerative diseases. We leverage novel, proprietary research tools and patient neuron cell-based in vitro disease models to develop transformative therapies aimed at slowing or halting the progression of Parkinson's disease (PD), Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and Gaucher disease (GD).